CRISPR/Cas is a promising tool to tackle genetic diseases. However, non-viral vectors with good transfection efficiency often struggle with high cytotoxicity. In the presented paper, calcium nanoparticles were modified with chitosan. The effects on transfection efficiency and cytotoxicity were then investigated.
At the beginning of the year 2015, an incredible large number of chitosan-related articles have been released, indicating another record year. All in all, 196 publications about chitosan and its derivatives were contributed by scientist from all over the world, especially from China (46 articles), India (29) and USA (15). The main terms address chitosan in evaluation studies, nanoparticles and pharmaceutical preparations.
14th PBP World Meeting/ Research Pharm, Vienna, Austria, 18.-21.03.2024
CPHI, Milan, Italy, 08.-10.10.2024
MEDICA 2024, Düsseldorf, Germany, 11.-14.11.2024
To arrange an appointment please contact Katja Richter via This email address is being protected from spambots. You need JavaScript enabled to view it.
Contact
Heppe Medical Chitosan GmbH Heinrich-Damerow-Strasse 1 06120 Halle (Saale) Germany
We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.